当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Raveendran AV
We are very delighted to announce that Journal of clinical diabetes launching the new issue release. The epidemic wave of Diabetes and its associated metabolic disorders is spreading to both developed as well as developing countries and carrying with it an increase in number of debilitating illnesses.
Journal of Clinical Diabetes is a peer-reviewed journal that aims to publish research dealing with Diabetes research such as: Type 1 and Type 2 Diabetes, Diabetic Nephropathy and retinopathy, Gestational Diabetes and covers all aspects of diabetes technology including: insulin and metabolic peptide delivery, glucose monitoring, Prediabetes, Latent autoimmune diabetes of adults etc.
In the Current research articles of clinical diabetes, Mahmoud HMA, et al. reported that there is an increase in serum Chitotriosidase in atherosclerotic diabetic patients than nonatherosclerotic diabetic one.
Our co-editorial board member VirojWiwanitkit conducted study on Coronavirus Infection and Diabetes Mellitus Pathogenesis. He explained the complex interrelationship between coronavirus and pathogenesis of diabetes